Email this article Relationship between representation and severity of Gilles de la Tourette syndrome and comorbidities
- Authors: Sofronov A.G.1, Zaytsev D.E.2, Zaytsev I.D.1, Titov N.A.2
-
Affiliations:
- North-Western State Medical University named after I.I. Mechikov
- Zaytsev’s psychoneurological center Ltd.
- Issue: Vol LII, No 1 (2020)
- Pages: 14-18
- Section: Original study arcticles
- URL: https://journals.rcsi.science/1027-4898/article/view/19428
- DOI: https://doi.org/10.17816/nb19428
- ID: 19428
Cite item
Full Text
Abstract
Aim. To study representation and distribution of comorbidities, their relationship with clinical presentation and severity of Gilles de la Tourette syndrome, with age of onset of motor and vocal tics.
Methods. Were examined 58 children (44 boys, 14 girls) at the age of 11.07±0.52 years (4–18 years old) with observation period from 1 to 10 years with diagnosis of Gilles de la Tourette syndrome. All patients were examined by child psychiatrist, neurologist, child psychologist to clarify diagnosis and psychopathological comorbidities. Comorbidities were determined by clinical-psychopathological method and by standardized scales.
Results. In the course of the research there were identified the main comorbid disorders, their representation, prevalence and relationship with tic disorder. The results of the study allow us to conceptualize separately comorbid disorders and complex tic-like symptoms. According to the study, comorbid disorders tend to develop on their own, while a number of specific features tend to manifest themselves, increasing representation during the course of development of the main tic disorder.
Conclusion. Such specific features as self-injurious behaviors, non-obscene, socially inappropriate behaviors, coprophenomena, echophenomena; and paliphenomend are proposed to be called complex tic-like symptoms. In our opinion, we should differentiate and separately classify complex tic-like symptoms from mental comorbidities, that have their own development regardless of the course of tics in Gilles de la Tourette syndrome.
Full Text
##article.viewOnOriginalSite##About the authors
Aleksandr G. Sofronov
North-Western State Medical University named after I.I. Mechikov
Email: alex-sofronov@yandex.ru
Professor, DMS, Head of psychiatry and narcology department
Russian Federation, 41, Kirochnaya street, Saint-Petersburg, 191015Dmitrij E. Zaytsev
Zaytsev’s psychoneurological center Ltd.
Email: dzaytsev@mail.ru
Phd, chief medical officer
Russian Federation, 191040, Saint-Petersburg, Ligovskiy pr., 50, lit. FIl’ya D. Zaytsev
North-Western State Medical University named after I.I. Mechikov
Author for correspondence.
Email: dr.zaytsev.ilya@gmail.com
psychiatrist, functional diagnostic doctor
Russian Federation, 41, Kirochnaya street, Saint-Petersburg, 191015Nikolaj A. Titov
Zaytsev’s psychoneurological center Ltd.
Email: titov_na@mail.ru
neurologist, functional giagnostic doctor
Russian Federation, 191040, Saint-Petersburg, Ligovskiy pr., 50, lit. FReferences
- Robertson M.M. The Gilles de la Tourette syndrome: The current status. Arch. Dis. Child Educ. PrCT Ed. 2012; 97:166–175. DOI: http://dx.doi.org/10.1136/archdischild-2011-300585.
- Debes N.M. Co-morbid disorders in Tourette syndrome. Behav. Neurol. 2003; 27: 7–14. doi: 10.3233/BEN-120275.
- American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention deficit/hyperactivity disorder. Pediatrics. 2000; 105: 1158–70.
- Hirschtritt M.E. Lifetime prevalence, age of risk, and etiology of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry. 2015; 72 (4): 325–333. doi: 10.1001/jamapsychiatry.2014.2650.
- Robertson M.M., Eapen V. Pharmacologic controversy of CNS stimulants in Gilles de la Tourette’s syndrome. Clin. Neuroparmacol. 1992; 15: 408–425.
- Sukhodolsky D.G., do Rosario-Campos M.C., Lombroso P.J. et al. Adaptive, emotional, and family functioning of children with obsessive-compulsive disorder and comorbid attention deficit hyperactivity disorder. Am. J. Psychiatry. 2005; 162: 1125–1132.
- Flamet M.F., Whitaker A., Rapoport J.L. et al. Obsessive compulsive disorder in adolescence: An epidemiological study. J. Am. Acad. of Child & Adolescent Psychiatry. 1988; 27: 764–771.
- Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000; 123 (3): 425–462.
- Zohar A.H., Ratzoni G., Pauls D.L. et al. An epidemiological study of obsessive-compulsive disorder and related disorders in Israeli adolescents. J. Am. Acad. of Child & Adolescent Psychiatry. 1992; 31: 1057–1061.
- Budman C.L., Rockmore L., Stokes J., Sossin M. Clinical phenomenology of episodic rage in children with Tourette syndrome. J. Psychosomat. Res. 2003; 55: 59–65.
- Kostanecka-Endress T., Banaschewski T., Kinkelbur J. et al. Disturbed sleep in children with Tourette syndrome. A polysomnographic study. J. Psychosomat. Res. 2003; 55: 23–29.
- Robertson M.M. Mood disorder and Gilles de la Tourette’s syndrome: an update on prevalence, etiology; comorbidity, clinical associations, and implications. J. Psychosomat. Res. 2006; 61: 349–358.
- Debes M.M., Hjalgrim H., Skov L. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome. J. Childhood Neurol. 2008; 23: 1017–1027.
- Kompoliti K. Sources of disability in Tourette syndrome: children vs. adults. Tremor and other Hyperkinetic Movements. 2016; 5: 318. doi: 10.7916/D8Z60NQ2.
- Tanvi S., Jacubovski E., Muller-Vahl K.R. New insights into clinical characteristics of Gilles de la Tourette Syndrome: Findings in 1032 patients from a Single German Center. Front. Neurosci. 2016; 10: 415. doi: 10.3389/fnins.2016.00415.
- Lowe T.L., Capriotti M.R., McBurnett K. Long-term follow-up of Patients with Tourette’s syndrome. Movement Dis. Clin. Pract. 2018; 6 (1): 40–45. doi: 10.1002/mdc3.12696.
- Groth C. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J. Am. Acad. of Child & Adolescent Psychiatry. 2017; 56 (4): 304–312. doi: 10.1016/j/jaac/2017.01.010.
- Cohen S., Leckman J.F. Clinical assessment of Tourette syndrome and tic disorders. Neurosci. Biobehav Rev. 2013; 37 (6): 997–1007. doi: 10.1016/j.neubiorev.2012.11.013.
- Сухотина Н.К., Егорова Т.И. Оценочные шкалы синдрома дефицита внимания с гиперактивностью. Социал. и клин. психиатрия. 2008; 18 (4): 15–21. [Sukhotina N.K., Egorova T.I. Assessment scales of attention deficit and hyperactive syndrome. Social and clinical psychiatry. 2008; 18 (4): 15–21. (Russ.)]
- Reynolds C.R., Richmond B.O. Factor structure and construct validity of “what I think and feel”: the revised children’s manifest anxiety scale. J. Personal Assessment. 1979; 43 (3): 281–283.
- Storch E.A., Murphy T.K., Adkins J.W. et al. The children’s Yale–Brown obsessive-compulsive scale: psychometric properties of child- and paren-report formats. J. Anxiety Dis. 2006; 20 (8): 1055–1070.
- Leckman J.F., Riddle M.A., Hardin M.T. et al. The Yale global tic severity scale: initial testing of a clinical-rated scale of tic severity. J. Am. Acad. Child Adolesc. Psychiatry. 1989; 28: 566–573.
- Yu D., Mathews C.A., Scharf J.M. et al. Cross disorder genome-wide analyses suggest a complex genetic relationship between Tourette’s syndrome and OCD. Am. J. Psychiatry. 2014; 172: 82–93. DOI: http://dx.doi.org/10.1176/appi.ajp.2014.13101306.
- Ludolph A.G., Roessner V., Munchau A., Muller-Vahl K. Tourette syndrome and other tic disorders in childhood, adolescence and adulthood. Deutsches Arzteblatt Intern. 2012; 109 (48): 821–828. doi: 10.3238/arztebl.2012.0821.
